Cusatuzumab combined with venetoclax with or without azacitidine in unfit patients with newly diagnosed acute myeloid leukemia: phase Ib ELEVATE study.

Roboz GJ, Pabst T, Aribi A, Brandwein JM, Döhner H, Fiedler W, Riether C, Gandini D, Geddes M, Hou JZ, Yee K, Hultberg A, Huselton E, Jacobs J, Zabrocki P, Lech-Marańda E, Louwers M, Nottage K, Platzbecker U, Rampal R, Salman M, Shah P, Wilson K, Stuart M, Subklewe M, Sumbul A, Wang ES, Wierzbowska A, Yao B, Patel R, George A, Islam N, Smith C, Boyiadzis M, Borthakur G

Open source

DOI: 10.3324/haematol.2026.300917
Published: 2026 Sep 3
Container: Haematologica
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3324/haematol.2026.300917,
  title = {Cusatuzumab combined with venetoclax with or without azacitidine in unfit patients with newly diagnosed acute myeloid leukemia: phase Ib ELEVATE study.},
  author = {Roboz GJ and Pabst T and Aribi A and Brandwein JM and Döhner H and Fiedler W and Riether C and Gandini D and Geddes M and Hou JZ and Yee K and Hultberg A and Huselton E and Jacobs J and Zabrocki P and Lech-Marańda E and Louwers M and Nottage K and Platzbecker U and Rampal R and Salman M and Shah P and Wilson K and Stuart M and Subklewe M and Sumbul A and Wang ES and Wierzbowska A and Yao B and Patel R and George A and Islam N and Smith C and Boyiadzis M and Borthakur G},
  year = {2026},
  journal = {Haematologica},
  doi = {10.3324/haematol.2026.300917},
  url = {https://doi.org/10.3324/haematol.2026.300917}
}

RIS

TY  - JOUR
TI  - Cusatuzumab combined with venetoclax with or without azacitidine in unfit patients with newly diagnosed acute myeloid leukemia: phase Ib ELEVATE study.
AU  - Roboz GJ
AU  - Pabst T
AU  - Aribi A
AU  - Brandwein JM
AU  - Döhner H
AU  - Fiedler W
AU  - Riether C
AU  - Gandini D
AU  - Geddes M
AU  - Hou JZ
AU  - Yee K
AU  - Hultberg A
AU  - Huselton E
AU  - Jacobs J
AU  - Zabrocki P
AU  - Lech-Marańda E
AU  - Louwers M
AU  - Nottage K
AU  - Platzbecker U
AU  - Rampal R
AU  - Salman M
AU  - Shah P
AU  - Wilson K
AU  - Stuart M
AU  - Subklewe M
AU  - Sumbul A
AU  - Wang ES
AU  - Wierzbowska A
AU  - Yao B
AU  - Patel R
AU  - George A
AU  - Islam N
AU  - Smith C
AU  - Boyiadzis M
AU  - Borthakur G
PY  - 2026
JO  - Haematologica
DO  - 10.3324/haematol.2026.300917
UR  - https://doi.org/10.3324/haematol.2026.300917
ER  -

APA

GJ, R., T, P., A, A., JM, B., H, D., W, F., C, R., D, G., M, G., JZ, H., K, Y., A, H., E, H., J, J., P, Z., E, L., M, L., K, N., U, P., R, R., M, S., P, S., K, W., M, S., M, S., A, S., ES, W., A, W., B, Y., R, P., A, G., N, I., C, S., M, B., & G, B. (2026). Cusatuzumab combined with venetoclax with or without azacitidine in unfit patients with newly diagnosed acute myeloid leukemia: phase Ib ELEVATE study.. Haematologica. https://doi.org/10.3324/haematol.2026.300917

Source records

pubmed · retrieved 2026-09-26T09:23:21.553Z